HopeStage
Back to all studies
TerminatedISRCTN93153882

Treatment outcome improvements by using Rx Report (a pharmacogenomic test) in depressive disorder patients

Research studyAges 18+CanadaDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: from 18 years.

Listed locations
Canada

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNot clearly listed
Recruitment status
Terminated
Enrollment listed in the registry
Not clearly listed
Sponsor
Personalized Prescribing Inc.
Sponsor type
Other organization
Study type
Other
Intervention type
Other / unclear
Locations
Canada
Age range
Over 18 Years
Official registry ID
ISRCTN93153882
Official title
Show the full official title

Treatment outcome improvements by using Rx Report (a pharmacogenomic test) in depressive disorder patients

Recruitment & locations

Terminated

Canada

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Personalized Prescribing Inc.

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies